Zantac set for front-of-shop return


TGA gives green light for Zantac’s reinstatement on the ARTG  Aspen Pharmacare Australia’s Zantac (ranitidine (as hydrochloride)) products are set to return to pharmacy and grocery stores’ shelves following its return to the Australian Register of Therapeutic Goods (ARTG).   The Therapeutic Goods Administration (TGA) removed all medicines containing ranitidine from the Australian market in

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous The week in review
Next Private label offers growth opportunities: Sigma